Found 7 matching trials
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors PHASE1 The main purpose of this study is to learn more about the safety, side effe...
Show More Location
Mayo Clinic of Scottsdale
Learn More & Join Trial
Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast Cancer PHASE2 This is a prospective, open-label, single-center, randomized controlled Pha...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial PHASE2 This phase II trial studies how well imlunestrant and abemaciclib work in t...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors PHASE1 Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study e...
Show More Location
Ellison Clinic at Saint John's
Learn More & Join Trial
A Study of LY4257496 in Participants With Cancer (OMNIRAY) PHASE1 The main purpose of this study is to evaluate safety, tolerability, and eff...
Show More Learn More & Join Trial
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer PHASE1 The reason for this study is to see if the study drug LY3484356 alone or in...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer PHASE3 The main purpose of this study is to measure how well imlunestrant works co...
Show More Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers
Learn More & Join Trial